Trials / Completed
CompletedNCT00627809
Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction
Phase 4 Study of Application of Intracoronary Low Dose Streptokinase Complementary to Standard Percutaneous Coronary Intervention in Patients With ST Elevation Acute Myocardial Infarction: Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Istanbul University · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesized that complementary intracoronary streptokinase administration to primary percutaneous intervention in patients with acute myocardial infarction may provide limitation infarct size and improvement in left ventricular volumes and function in acute and late phases (6 months).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Streptokinase | intracoronary infusion, 250.000 Units |
| PROCEDURE | primary percutaneous coronary intervention | balloon catheter, stent |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2008-01-01
- Completion
- 2008-02-01
- First posted
- 2008-03-03
- Last updated
- 2009-06-23
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT00627809. Inclusion in this directory is not an endorsement.